" class="no-js "lang="en-US"> University of Liverpool - Medtech Alert
Tuesday, April 16, 2024

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
University of Liverpool | Pharmtech Focus

University of Liverpool

About University of Liverpool

University of Liverpool

The University of Liverpool is one of the great centres of research, knowledge and innovation. Our pioneering reputation attracts students, experts and partners from around the world. Through our research, teaching and collaborations we seek to be life changing and world shaping.

Related Story

Company Releases

 New £12.7M Centre of Excellence in Emerging Digital Technologies Officially Opens | Pharmtech Focus

New £12.7M Centre of Excellence in Emerging Digital Technologies Officially Opens

May 24 2022

The University of Liverpool’s Digital Innovation Facility (DIF), a £12.7 million Centre of Excellence in […]

Fundraising

 Innova Medical Group Gifts £10m to Launch Global Pandemic Institute in Liverpool | Pharmtech Focus

Innova Medical Group Gifts £10m to Launch Global Pandemic Institute in Liverpool

September 14 2021

Innova Medical Group, a global health innovator and the world’s largest provider of rapid antigen […]